On Monday, Shares of Walt Disney Co (NYSE:DIS), added 0.25% and closed at $97.92 in the last trading session. The last trading range of the stock ranges between $97.45 and $98.31. The company’s Market capitalization is $161.87 Billion with the total Outstanding Shares of 1.60 billion. During the 52-week trading session the minimum price at which share price traded, registered at $86.25 and reached to max level of $120.65. The EPS of company is strolling at 5.72. Disney Store recently unveiled its Magical Friday (aka Black Friday) deals and special in-store holiday events – nearly two weeks before the Thanksgiving holiday shopping weekend. Starting recently in-store and online, guests can expect to see up to 40% off thousands of items, with more deals to roll out in the coming days and when Stores open on Thanksgiving night (11/24), Magical Friday (11/25) and Cyber Monday* (11/28).
Guests have the opportunity to shop Disney Store whenever and wherever through DisneyStore.com and the newly improved Disney Store app where they’ll find great deals on exclusive Disney, Pixar, Marvel and Star Wars items for everyone on their list.
“There is so much to be excited about this holiday, with products inspired by the theatrical release of Disney ‘Moana’ and ‘Rogue One: A Star Wars Story,’ in addition to fan favorites like Disney ‘Elena of Avalor’ and Disney-Pixar Toy Story,” said Elissa Margolis, senior vice president of Disney Store North America. “With our deals starting two weeks before Magical Friday, and accessible in-store, online and via our mobile app, guests are sure to find something for everyone on their lists.”
Shares of Novavax, Inc. (NASDAQ:NVAX), dropped -2.88% and closed at $1.35 in the last trading session. The last trading range of the stock ranges between $1.32 and $1.45. The company’s Market capitalization is $363.49 million with the total Outstanding Shares of 271.25 million. During the 52-week trading session the minimum price at which share price traded, registered at $1.16 and reached to max level of $9.23. The EPS of company is strolling at -1.12. Novavax, Inc., (NVAX) recently declared its financial results for the third quarter and nine months ended September 30, 2016, in conjunction with its Shareholder and Analyst Day update.
The Company presented a restructuring plan designed to meet the following key objectives:
Prioritize development activities to achieve clinical data events within 2017;
Reduce cash burn, extend financial horizon and minimize near-term dilution; and
Maintain operational core competencies to execute development plans.
The restructuring includes an immediate reduction in workforce of about 30%. The Company anticipates to incur one-time restructuring costs of about $3 million to $4 million, counting severance expenses, in the fourth quarter of 2016. In addition, administration has initiated expense reduction measures regardingpre-commercialization activities, capital equipment investments, project specific and general research and development, and general and administrative expenses. As a result of the restructuring, Novavax estimates a reduction in cash burn of $70 million to $100 million in 2017 relative to 2016.